Protein kinase inhibitor

Details Protein kinase inhibitor Protein kinase inhibitor

1997-04-03

1998-12-29

MacMillan, Keith D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514523, 514525, A61K 3121, A61K 3126, A61K 31275

Patent

active

058542850

ABSTRACT:
A compound of the formula I ##STR1## wherein A and C are independently H, alkyl of 1-6 carbon atoms, hydroxy, or alkoxy of 1-6 carbon atoms;

REFERENCES:
patent: 5196446 (1993-03-01), Levitzki et al.
patent: 5217999 (1993-06-01), Levitzki et al.
patent: 5266594 (1993-11-01), Dawson et al.
patent: 5302606 (1994-04-01), Spada et al.
patent: 5385915 (1995-01-01), Buxbaum et al.
Galea, E., et al. (1995) "Differential suppression of glial nitric oxide synthase induction by structurally related tyrosine kinase inhibitors," Neuroscience Lett. 200:195-198.
Gazit et al., (1989) J. Med. Chem., 32:2344-2352.
Gazit et al., (1991) J. Med. Chem., 34:1896-1907.
Gazit et al., (1993) J. Med. Chem. 36:3556-3564.
Katsumi, I., et al. (1985) Chem Pharm. Bull. "Studies on Styrene Derivatives.II. Synthesis and Antiinflammatory Activity of 3,5-Di-tert-butyl-4-hydroxystyrenes," 34:1619-1627.
Kenatharan, M., et al. (1996) Brit. J. of Pharm. "Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages." 117:1163-1170.
Levitzki, A. (1992) "Typhstins: tyosine kinase blockers as novel antiproliferative agent and dissector of signal transduction," The FASEB Journal 6:3275-3282.
Novogrodsky, A., et al. (1994) "Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase Inhibitors," Science 264:1319-1322.
Shiraishi, T., et al. (1987) "Specific Inhibitors of Tyrosine-Specific Protein Kinases. I. Synthesis and Inhibitory Activities of .alpha.-Cyanocinnamamides," Chem. Pharm. Bull. 36:974-981.
Tan, C.M., et al. (1995) "Oxidant Stress Enhances Adenylyl Cyclease Activation," Circulation Research 77:710-717.
Vanickin, A., et al. (1995) "Late Administration of a Lipophilic Tyrosine Kinases Inhibitor Prevents Lipopolysaccharide and Escherichia coli-Induced Lethal Toxicity," J. Infectious Diseases 173:927-933.
LC Laboratories Catalog Pages, pp.217, 218, 220.

Affiliated with

Also associated with

Rating

Protein kinase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein kinase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein kinase inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1425245